UnknownNot Applicable

Functional Outcome After Treatment for Oropharyngeal Squamous Cell Carcinoma

Denmark44 participantsStarted 2017-04-01

Plain-language summary

To investigate the treatment related effects of transoral robotic surgery (TORS) or oncological treatment of oropharyngeal squamous cell carcinoma with a 1-year follow up.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. WHO performance status 0-2
✓. Squamous cell carcinoma of the oropharynx
✓. TNM: T1-2, N0-1 (without of evidence of extra capsular extent), M0.
✓. No previous head and neck cancer
✓. Absence of factors that inhibit the patient from participate in all or parts of the study e.g. geographical, mental, cognitive or other.
✓. Signed written consent.
✓. Cancer eligible for surgery in the absence of significant trismus.
✓. WHO performance status 0-2

Exclusion criteria

✕. Serious co-morbidity
✕. Distant metastasis
✕. Previous radiotherapy to the head and neck region.
✕. Concurrent treatment eller investigations for another cancer, except carcinoma in situ.
✕. Previous radiotherapy to the head and neck region.
✕. Concurrent treatment eller investigations for another cancer, except carcinoma in situ.
✕. Presence of factors that inhibit the patient from participate in all or parts of the study e.g. geographical, mental, cognitive or other.
✕. Presence of facors that inhibit the patient from completing the treatment.

What they're measuring

Altered salivatory function

Timeframe: 3 and 12 months follow up

Trial details

NCT IDNCT03418909

SponsorRigshospitalet, Denmark

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-12-31

View on ClinicalTrials.gov More Oropharynx Cancer trials